Trained immunity in hyperuricemia and gout: Targeting epigenetic marks to reduce cardiovascular risk

Nils Asmann, Brenda Kischkel, Leo A.B. Joosten
Current Opinion in Pharmacology · Elsevier · 2026-12-01 · DOI: 10.1016/j.coph.2026.102664

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles